New MS Drug Approved 2009
Links shared publicly online about this topic
2 New Drugs May Fight Multiple Sclerosis
webmd.com — “Two new oral drugs cut by about half the relapse rate in people with multiple sclerosis (MS).” View full resource at webmd.com
Most Recently Shared on May 4, 2009 at 3:29 pm By:
2 New Drugs May Fight Multiple Sclerosis: Two new oral drugs cut by about half the relapse rate in people with m.. http://tinyurl.com/cxt5z7
Multiple Sclerosis Drug Gilenya Approved in Russia | ThirdAge
thirdage.com — “The Multiple Sclerosis drug, Gilenya, manufactured by Novartis has been approved for use in Russia. The drug is a daily oral therapy for treating relapses of multiple sclerosis. Russia is the first country to approve the use of the drug for treating MS.” View full resource at thirdage.com
Most Recently Shared on September 16, 2010 at 1:28 am By:
Multiple Sclerosis Drug Gilenya Approved in Russia: The Multiple Sclerosis drug, Gilenya, manufactured by Novartis... http://bit.ly/buTAb7
Multiple Sclerosis Drug Gilenya Approved in Russia | ThirdAge
thirdage.com — “The Multiple Sclerosis drug, Gilenya, manufactured by Novartis has been approved for use in Russia. The drug is a daily oral therapy for treating relapses of multiple sclerosis. Russia is the first country to approve the use of the drug for treating MS.” View full resource at thirdage.com
Most Recently Shared on September 15, 2010 at 11:26 pm By:
Multiple Sclerosis Drug Gilenya Approved in Russia http://bit.ly/b5Wg6T
Merck?s Cladribine Tablets for Multiple Sclerosis Approved in Australia - Drugs.com MedNews
drugs.com — “Darmstadt, September 3, 2010 Merck KGaA announced today that the Australian Therapeutic Goods Administration (TGA) has approved Cladribine Tablets for the treat” View full resource at drugs.com
Most Recently Shared on September 3, 2010 at 12:11 pm By:
Drugs and Devices OW OW Health
Merck?s Cladribine Tablets for Multiple Sclerosis Approved in Australia: Darmstadt, September 3, 2010 – Merck... http://bit.ly/aAu3a7 #drug
Merck?s Cladribine Tablets for Multiple Sclerosis Approved in Australia - Drugs.com MedNews
drugs.com — “Darmstadt, September 3, 2010 Merck KGaA announced today that the Australian Therapeutic Goods Administration (TGA) has approved Cladribine Tablets for the treat” View full resource at drugs.com
Most Recently Shared on September 4, 2010 at 11:41 am By:
Merck?s Cladribine Tablets for Multiple Sclerosis Approved in Australia: Darmstadt, September 3, 2010 – Merck KGaA... http://bit.ly/bhIY9L
FDA approves first oral drug to slow multiple sclerosis progression - latimes.com
latimes.com — “Fingolimod, a failed anti-rejection drug, is the latest medication that aims to slow the progression of disability in MS” View full resource at latimes.com
Most Recently Shared on September 22, 2010 at 11:10 pm By:
LA Times Health News Health News
FDA approves first oral drug to slow multiple sclerosis progression http://lat.ms/dz93q0
FDA Panel: New MS Drug Ampriva Helps Walking
webmd.com — “Ampriva helps some multiple sclerosis patients walk better, an FDA advisory panel says. The finding makes it more likely that full FDA approval will come soon.” View full resource at webmd.com
Most Recently Shared on October 16, 2009 at 9:07 pm By:
FDA Panel: New MS Drug Helps Walking: Ampriva helps some multiple sclerosis patients walk better, an FDA advisor.. http://bit.ly/18sLkD
Oral MS Drug Fampridine is Trifecta of Firsts for People with MS, Says National MS Society
prweb.com — “Pr: fda approves fampridine sr, now called ampyra, to improve walking for people with all types of multiple sclerosis. ampyra is the first symptom management drug developed specifically to treat ms, the first oral therapy approved for ms and the first new fda-approved therapy for ms since 2004. new york” View full resource at prweb.com
Most Recently Shared on January 23, 2010 at 2:40 am By:
Oral MS drug Fampridine is a trifecta of"firsts" for people with multiple sclerosis http://tinyurl.com/yhbszro
Fast Forward, LLC and Amplimmune, Inc. Join Forces to Speed New Treatments to People with MS**
prweb.com — “Pr: companies announce a collaboration for the development of amp-110 - an innovative treatment for multiple sclerosis and other autoimmune diseases new york, ny/rockville, md (vocus/prweb ) august 26, 2009 -- amplimmune, inc., a m” View full resource at prweb.com
Most Recently Shared on August 25, 2009 at 2:03 pm By:
Fast Forward partnership with Amplimmune expands our role in spurring MS drug development in biotech market http://tinyurl.com/nxkngp
New research may lead to therapy that delays onset, reduces severity of MS symptoms
physorg.com — “People suffering from multiple sclerosis may benefit if patent-pending research conducted at Purdue University shows that a decades-old drug approved by the FDA to treat hypertension also can delay the onset and reduce the severity of MS symptoms.” View full resource at physorg.com
Most Recently Shared on March 15, 2011 at 6:30 pm By:
New research may lead to therapy that delays onset, reduces severity of MS symptoms: People suffering from multi... http://bit.ly/h1gqw0
2 New Drugs May Fight Multiple Sclerosis#1 - WEGO Health
community.wegohealth.com — “2 New Drugs May Fight Multiple Sclerosis#1 2 New Drugs May Fight Multiple Sclerosis#1 Study Shows Cladribine and Fingolimod Cut Relapse Rate in MS Patients By Charlene Laino WebMD Health News Reviewed by Louise Chang, MD April 30, 2009 (Seattle) -- Two new oral drugs cut by about half the relapse rate in people with multiple sclerosis (MS). If approved by the FDA, the drugs -- cladribine and fingolimod -- would become the first treatments for MS that don't involve regular injections or infusions” View full resource at community.wegohealth.com
Most Recently Shared on November 30, 2009 at 7:28 am By:
Our Aloe Business Health Business
2 New Drugs May Fight Multiple Sclerosis#1 http://bit.ly/6Schni
US FDA Approves Extavia(R) - The First In A New Portfolio Of Planned MS Therapies From Novartis To Help Patients With This Devastating Disease
medicalnewstoday.com — “The US Food and Drug Administration (FDA) has approved Extavia(R) (interferon beta-1b), the first in a new planned portfolio of multiple sclerosis (MS) medicines from Novartis to help patients man” View full resource at medicalnewstoday.com
Most Recently Shared on August 18, 2009 at 12:56 pm By:
MedNewsToday: US FDA Approves Extavia(R) - The First In A New Portfolio Of Planned MS Therapies Fro.. http://bit.ly/MMOBo
US FDA approves Extavia - the first in a new portfolio of planned MS therapies from Novartis to help patients with this devastating disease
novartis.com — “Basel, August 17, 2009 - The US Food and Drug Administration (FDA) has approved Extavia (interferon beta-1b), the first in a new planned portfolio of multiple sclerosis (MS) medicines from Novartis to help patients manage this devastating disease.” View full resource at novartis.com
Most Recently Shared on August 20, 2009 at 1:30 pm By:
eyeonfda Pharma and Health Lawyer
FDA approves Novartis' Extavia® for treatment of MS - http://bit.ly/sM6J3
2009 in Review
jpnonline.com — “The Clip & Save: Drug Chart is a concise, up-to-date source of information on current medications for psychiatric illnesses. This section provides an opportunity to continually improve psychotro” View full resource at jpnonline.com
Most Recently Shared on January 19, 2010 at 2:15 pm By:
Clip & Save: Drug Chart 2009 in review http://ow.ly/WNwr
New antiarrhythmic dronedarone approved in Europe
theheart.org — “CORRECTED // The new antiarrhythmic agent dronedarone has been approved in the European Union and will be launched in its first markets there, in Germany and the UK, in the New Year.” View full resource at theheart.org
Most Recently Shared on December 1, 2009 at 1:10 pm By:
Dronedarone approved in European Union http://bit.ly/4Y2K4M #heartwire
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Featuring the top 3 experts for this topic
-
WebMD_News
The leading source for trustworthy and timely health news and information.
-
OrganizedWisdom MS
Organizing multiple sclerosis resources shared by health experts, advocates, and organizations into WisdomCards.
-
ThirdAge.com
A boomer's guide to a life of health, happiness, passion & purpose.
Advertisement
